{"result":[{"lastName":"Volkmer","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute"}],"primaryAppointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9789&type=small&showNoImage","displayName":"Jens-Peter Volkmer","firstName":"Jens-Peter","href":"http://med.stanford.edu/profiles/Jens-Peter_Volkmer","researchInterest":""},{"lastName":"Majeti","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Hematology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Hematology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=8250&type=small&showNoImage","displayName":"Ravindra Majeti","firstName":"Ravindra","href":"http://med.stanford.edu/profiles/Ravindra_Majeti","researchInterest":"Ravindra Majeti focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly acute myeloid leukemia (AML LSC). A major focus is the identification of cell surface molecules preferentially expressed on LSC and the development of therapeutic monoclonal antibodies targeting these proteins. Toward this goal, together with Irv Weissman, the lab is actively developing an anti-CD47 antibody for clinical trials in human AML."},{"lastName":"Alizadeh","clinicalFocus":[{"focus":"Oncology"},{"focus":"Lymphoma"},{"focus":"B-Cell Chronic Lymphocytic Leukemia"},{"focus":"Waldenstrom Macroglobulinemia"},{"focus":"Burkitt Lymphoma"},{"focus":"Follicular Lymphoma"},{"focus":"Diffuse Large-Cell Lymphomas"},{"focus":"Leukemia, Hairy Cell"},{"focus":"Lymphoma, B-Cell, Marginal Zone"},{"focus":"Hodgkin Disease"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9558&type=small&showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://med.stanford.edu/profiles/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Volkmer","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Stem Cell"}],"primaryAppointment":"Postdoctoral Research fellow, Stem Cell","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=20943&type=small&showNoImage","displayName":"Anne Kathrin Volkmer","firstName":"Anne","href":"http://med.stanford.edu/profiles/Anne_Volkmer","researchInterest":""},{"lastName":"Weissman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Pathology - Stem Cell Institute"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Developmental Biology"},{"appointment":"Professor (By courtesy),Biology (School of Humanities and Sciences)"}],"primaryAppointment":"Professor,Pathology - Stem Cell Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4605&type=small&showNoImage","displayName":"Irving Weissman","firstName":"Irving","href":"http://med.stanford.edu/profiles/Irving_Weissman","researchInterest":"Stem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis."},{"lastName":"Sahoo","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Pathology - Stem Cell Institute"}],"primaryAppointment":"Instructor,Pathology - Stem Cell Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10888&type=small&showNoImage","displayName":"Debashis Sahoo","firstName":"Debashis","href":"http://med.stanford.edu/profiles/Debashis_Sahoo","researchInterest":""},{"lastName":"Beck","clinicalFocus":[],"appointments":[{"appointment":"Ph.D., Dean's Office"}],"primaryAppointment":"Ph.D., Dean's Office","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=18189&type=small&showNoImage","displayName":"Andrew Beck","firstName":"Andrew","href":"http://med.stanford.edu/profiles/Andrew_Beck","researchInterest":""},{"lastName":"van de Rijn","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Sarcoma"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","displayName":"Matt van de Rijn","firstName":"Matt","href":"http://med.stanford.edu/profiles/Matt_van de Rijn","researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis."},{"lastName":"Duque Afonso","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Pathology"}],"primaryAppointment":"Postdoctoral Research fellow, Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=29334&type=small&showNoImage","displayName":"Atilio Jesus Duque-Afonso","firstName":"Atilio","href":"http://med.stanford.edu/profiles/Atilio_Duque Afonso","researchInterest":""},{"lastName":"Arvin","clinicalFocus":[{"focus":"Infectious Diseases, Pediatric"},{"focus":"Pediatric Infectious Disease"}],"appointments":[{"appointment":"Professor,Pediatrics - Infectious Diseases"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Professor,Microbiology & Immunology"}],"primaryAppointment":"Professor,Pediatrics - Infectious Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4188&type=small&showNoImage","displayName":"Ann M. Arvin","firstName":"Ann","href":"http://med.stanford.edu/profiles/Ann_Arvin","researchInterest":"Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells  in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections."},{"lastName":"Medeiros","clinicalFocus":[{"focus":"Hematology"},{"focus":"Acute leukemia"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7743&type=small&showNoImage","displayName":"Bruno Medeiros","firstName":"Bruno","href":"http://med.stanford.edu/profiles/Bruno_Medeiros","researchInterest":"My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia."},{"lastName":"Skinner","clinicalFocus":[{"focus":"Cancer > urologic oncology"},{"focus":"Bladder Cancer"},{"focus":"Continent urinary reservoir"},{"focus":"urinary tract reconstruction"},{"focus":"testis cancer"},{"focus":"Kidney Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor - Med Center Line,Urology"}],"primaryAppointment":"Professor - Med Center Line,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=32891&type=small&showNoImage","displayName":"Eila C. Skinner","firstName":"Eila","href":"http://med.stanford.edu/profiles/Eila_Skinner","researchInterest":"My research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer.  This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management.  I have also focused on optimizing the  use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life."},{"lastName":"Tan","clinicalFocus":[{"focus":"Pathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Clinical Assistant Professor,Pathology"}],"primaryAppointment":"Clinical Assistant Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6772&type=small&showNoImage","displayName":"Brent Tan","firstName":"Brent","href":"http://med.stanford.edu/profiles/Brent_Tan","researchInterest":"My research interest is in the use of molecular methods to understand and characterize hematopoietic neoplasms.  My current work focuses on the use of PCR-based assays for clonal rearrangements in the immunoglobulin heavy chain gene (IGH) and T-cell receptor gene (TCR) for the diagnosis of mature T-cell lymphomas."},{"lastName":"Withana","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Pathology"}],"primaryAppointment":"Postdoctoral Research fellow, Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=33579&type=small&showNoImage","displayName":"Nimali Withana","firstName":"Nimali","href":"http://med.stanford.edu/profiles/Nimali_Withana","researchInterest":""},{"lastName":"Kopito","clinicalFocus":[],"appointments":[{"appointment":"Professor,Biology (School of Humanities and Sciences)"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Biology (School of Humanities and Sciences)","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6227&type=small&showNoImage","displayName":"Ron Kopito","firstName":"Ron","href":"http://med.stanford.edu/profiles/Ron_Kopito","researchInterest":"Our research is concerned with elucidating the basic cellular molecular mechanisms that underly the recognition and destruction of misfolded or mis-assembled proteins in eukaryotic cells.  We study dominatly inherited human neurodegenerative disorders like Alzheimer's, Huntington's or Parkinson's diseases that are caused by the failure of this system to effectively recognize and destroy such proteins."},{"lastName":"Levy","clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4608&type=small&showNoImage","displayName":"Ronald Levy, MD","firstName":"Ronald","href":"http://med.stanford.edu/profiles/Ronald_Levy","researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer."},{"lastName":"Hu","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor,Obstetrics & Gynecology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor,Obstetrics & Gynecology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10405&type=small&showNoImage","displayName":"Mickey Hu","firstName":"Mickey","href":"http://med.stanford.edu/profiles/Mickey_Hu","researchInterest":""},{"lastName":"Mitra","clinicalFocus":[],"appointments":[{"appointment":"Senior Research Scientist,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute"}],"primaryAppointment":"Senior Research Scientist,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9478&type=small&showNoImage","displayName":"Siddhartha Mitra","firstName":"Siddhartha","href":"http://med.stanford.edu/profiles/Siddhartha_Mitra","researchInterest":"Glioblastoma multiforme, the most common malignant brain tumor in adults has a diffuse tissue-distribution pattern, with extensive dissemination within the brain that hinders complete surgical resection leading to an extremely poor prognosis despite advances in the field.  One of the main focus of my research in Dr Wong's lab is on identifying & targeting brain tumor stem cells from high grade tumors, especially those that express an epidermal growth factor receptor variant called EGFRvIII."},{"lastName":"Gitler","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor,Genetics"}],"primaryAppointment":"Associate Professor,Genetics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=29296&type=small&showNoImage","displayName":"Aaron D. Gitler","firstName":"Aaron","href":"http://med.stanford.edu/profiles/Aaron_Gitler","researchInterest":"We investigate the mechanisms of human neurodegenerative diseases, including Alzheimer disease, Parkinson disease, and ALS. We don't limit ourselves to one model system or experimental approach. We start with yeast, perform genetic and chemical screens, and then move to other model systems (e.g. mammalian tissue culture, mouse, fly) and even work with human patient samples (tissue sections, patient-derived cells, including iPS cells) and next generation sequencing approaches."},{"lastName":"Tsetsenis","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Neurosciences Institute"}],"primaryAppointment":"Postdoctoral Research fellow, Neurosciences Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10368&type=small&showNoImage","displayName":"Theodoros Tsetsenis","firstName":"Theodoros","href":"http://med.stanford.edu/profiles/Theodoros_Tsetsenis","researchInterest":""},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Hematopathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3925&type=small&showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://med.stanford.edu/profiles/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Gonzalgo","clinicalFocus":[{"focus":"Prostate Cancer - Robotic Prostatectomy"},{"focus":"Bladder Cancer - Robotic Cystectomy"},{"focus":"Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Urology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=13213&type=small&showNoImage","displayName":"Mark L. Gonzalgo, M.D., Ph.D.","firstName":"Mark","href":"http://med.stanford.edu/profiles/Mark_Gonzalgo","researchInterest":"My laboratory is focused on studying the role of DNA methylation in prostate and bladder cancer.  Certain genes and their downstream targets may be useful molecular markers for disease detection and prognostication. We are interested in utilizing methylation markers to detect abnormal changes in serum and urine.  Clinical Focus: Prostate Cancer - Robotic Prostatectomy; Bladder Cancer - Robotic Cystectomy; Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer."},{"lastName":"Giaccia","clinicalFocus":[],"appointments":[{"appointment":"Professor,Radiation Oncology - Radiation and Cancer Biology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor (By courtesy),Obstetrics & Gynecology"},{"appointment":"Professor (By courtesy),Surgery"}],"primaryAppointment":"Professor,Radiation Oncology - Radiation and Cancer Biology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4141&type=small&showNoImage","displayName":"Amato J. Giaccia","firstName":"Amato","href":"http://med.stanford.edu/profiles/Amato_Giaccia","researchInterest":"During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically."}]}